关注
Michal Dibus
Michal Dibus
Postdoc at Ivaskalab
在 utu.fi 的电子邮件经过验证
标题
引用次数
引用次数
年份
The interaction of p130Cas with PKN 3 promotes malignant growth
J Gemperle, M Dibus, L Koudelková, D Rosel, J Brábek
Molecular Oncology 13 (2), 264-289, 2019
212019
ARHGAP42 is activated by Src-mediated tyrosine phosphorylation to promote cell motility
W Luo, R Janoštiak, O Tolde, LM Ryzhova, L Koudelková, M Dibus, ...
Journal of cell science 130 (14), 2382-2393, 2017
192017
Novel modified leucine and phenylalanine dipeptides modulate viability and attachment of cancer cells
R Jorda, P Magar, D Hendrychova, K Pauk, M Dibus, E Pilařová, ...
European Journal of Medicinal Chemistry 188, 112036, 2020
172020
Structural characterization of CAS SH3 domain selectivity and regulation reveals new CAS interaction partners
J Gemperle, R Hexnerová, M Lepšík, P Tesina, M Dibus, M Novotný, ...
Scientific reports 7 (1), 8057, 2017
142017
Increased level of long non-coding RNA MALAT1 is a common feature of amoeboid invasion
L Merta, A Gandalovičová, V Čermák, M Dibus, T Gutschner, S Diederichs, ...
Cancers 12 (5), 1136, 2020
62020
A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings
Q Li, M Dibus, A Casey, CSK Yee, SO Vargas, S Luo, SM Rosen, ...
PLoS genetics 17 (7), e1009639, 2021
42021
A screen for PKN3 substrates reveals an activating phosphorylation of ARHGAP18
M Dibus, J Brábek, D Rösel
International Journal of Molecular Sciences 21 (20), 7769, 2020
42020
Novel tools to study cell-ECM interactions, cell adhesion dynamics and migration
M Dibus, O Joshi, J Ivaska
Current Opinion in Cell Biology 88, 102355, 2024
12024
系统目前无法执行此操作,请稍后再试。
文章 1–8